Enalapril

Known as: Enalaprila, Enalaprilum, (S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline 
A dicarbocyl-containing peptide and angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As a prodrug, enalapril is… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
BACKGROUND We compared the angiotensin receptor-neprilysin inhibitor LCZ696 with enalapril in patients who had heart failure with… (More)
  • figure 1
  • table 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
The Editorialists Reply: Garratt and Bailey suggest that our statement that CABG surgery is the preferred approach to… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Recent reports suggest that existing antihypertensive agents may not have sufficient efficacy to control blood… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 5
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Elevated renin-angiotensin-aldosterone system activity correlates with left ventricular hypertrophy (LVH) and… (More)
  • figure 1
  • table 1
  • table 2
  • figure 3
  • figure 2
Is this relevant?
Highly Cited
1999
Highly Cited
1999
BACKGROUND We investigated the effects of candesartan (an angiotensin II antagonist) alone, enalapril alone, and their… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
1998
Highly Cited
1998
BACKGROUND It has recently been reported that the use of calcium-channel blockers for hypertension may be associated with an… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
BACKGROUND It is not known whether the treatment of patients with asymptomatic left ventricular dysfunction reduces mortality and… (More)
Is this relevant?
Highly Cited
1991
Highly Cited
1991
BACKGROUND To define better the efficacy of vasodilator therapy in the treatment of chronic congestive heart failure, we compared… (More)
Is this relevant?
Highly Cited
1987
Highly Cited
1987
  • The New England journal of medicine
  • 1987
To evaluate the influence of the angiotensin-converting-enzyme inhibitor enalapril (2.5 to 40 mg per day) on the prognosis of… (More)
Is this relevant?